ANNAPOLIS, Md., Aug. 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
(Amex: HAQ), a biodefense company developing and commercializing medical
countermeasures against biological and chemical threats, today announced
that the Company's common stock and warrants will resume trading today on
the American Stock Exchange under the original symbol "HAQ" as to the
Company's common shares and "HAQ.WS" as to its warrants. Trading is
expected to resume at approximately 2:45 p.m. today, August 7, 2007.
Effective tomorrow, trading will occur under the Company's new symbol "PIP"
as to its common shares and "PIP.WS" as to its warrants.
PharmAthene intends to conduct an investor conference call to address
questions related to the recent merger of Healthcare Acquisition Corp. and
PharmAthene. Further information about the conference call will be provided
shortly.
Additional Information
PHARMATHENE CLAIMS THE PROTECTION OF THE SAFE HARBOR FOR
"FORWARD-LOOKING STATEMENTS" WITHIN THE MEANING OF THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995. FORWARD-LOOKING STATEMENTS ARE STATEMENTS
THAT ARE NOT HISTORICAL FACTS. SUCH FORWARD-LOOKING STATEMENTS, BASED UPON
THE CURRENT BELIEFS AND EXPECTATIONS OF MANAGEMENT OF PHARMATHENE
REGARDING, AMONG OTHER THINGS, THE POTENTIAL DETERMINATIONS BY A COURT OF
CHANCERY IN DELAWARE AS TO THE VALIDITY OF THE APPROVAL OF THE MERGER,
WHICH CANNOT BE PREDICTED WITH CERTAINTY. NO ASSURANCES CAN BE GIVEN THAT
OTHER PARTIES WILL NOT OPPOSE CONFIRMATION OF SUCH VALIDITY.
About PharmAthene, Inc.
PharmAthene was a privately-held biodefense company, was formed in 2001
to meet the critical needs of the United States by developing biodefense
products. PharmAthene is dedicated to the rapid development of important
and novel biotherapeutics to address biological pathogens and chemicals
that may be used as weapons of bioterror. PharmAthene's lead programs
include Valortim(TM) and Protexia(R). For more information on PharmAthene,
please visit its website at http://www.PharmAthene.com. Following approval
of the merger at HAQ's Special Meeting of Stockholders held on Friday,
August 3, 2007, the name of PharmAthene was changed to "PharmAthene US
Corporation."
About Healthcare Acquisition Corp.
Des Moines-based Healthcare Acquisition Corp. was jointly formed by
healthcare investing pioneers, John Pappajohn and Derace L. Schaffer, M.D.
Healthcare Acquisition Corp. was a special purpose acquisition company
focused on the healthcare industry. The Company's shares traded on the
American Stock Exchange, under the symbol HAQ and its warrants traded on
the American Stock Exchange under the symbol HAQW. Following HAQ's Special
Meeting of Stockholders held on Friday, August 3, 2007, the name of HAQ was
changed to "PharmAthene, Inc."
SOURCE PharmAthene, Inc.
 back to top
Related links:
http://www.PharmAthene.com
CONTACT:
Stacey Jurchison of PharmAthene, Inc.,
+1-410-269-2610, JurchisonS@PharmAthene.com
|
